Neurodiagnostics Market
Neurodiagnostics Market - Global Industry Assessment & Forecast
#
Pages:
210
2024
Dec - 2024
VMR-3681
Segments Covered
By
Product Diagnostic and Imaging Systems, Electroencephalogram (EEG) Systems, Electromyography (EMG) Products, Magnetic Resonance Imaging (MRI) Systems, Ultrasound Imaging Systems, Computed Tomography (Ct) Scanner, Magnetoencephalogram (Meg) System, Position Emission Tomography (Pet) System, Angiography System, Other Systems, Clinical Testing Instruments, PCR, Next-Generation Sequencing (NGS), Sanger Sequencing, Other Clinical Diagnostic Products, Reagents & Consumables, Media and Serra, Solvents, Enzymes, Protein & Peptides, Probes, Buffers, Antibodies, Other Reagents
-
By
Condition Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders, Other Diseases
-
By
End User Hospitals and Surgery Centers, Neurology Centers, Ambulatory Care Centers, Diagnostic Laboratories & Imaging Centers, Research Laboratories & Academic Institutes
-
By
Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
 Base Year:
|
2024 |
| Forecast
Years:
|
2025 - 2034 |
 Historical
Years:
|
2019 - 2023 |
 Revenue
2024: |
USD XX Billion |
 Revenue 2034:
|
USD XX Billion |
 Revenue CAGR
(2025 - 2034): |
7.4% |
Fastest Growing Region (2025 -
2034)
|
North America |
Largest Region (2024):
|
XX |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
| Sr. No. | Offering | Report Coverage |
| 1. | Market Size | In terms of Revenue (USD Million) |
| 2. | Historic Data | 2019 to 2023 |
| 3. | Forecast Data | 2025 to 2034 |
| 4. | Market Drivers, Restraints, Opportunities, & Regional Market Trends | Yes |
| 5. | Market Attractiveness Analysis | Yes |
| 6. | Segment Analysis | Maximum Segments |
| 7. | Regional Coverage | 5 Regions |
| 8. | Country Coverage | Top 22 Countries |
| 9. | Competitive Landscape and Company Market Share Analysis | Yes. Exhaustive information will be provided in two separate chapters of Competitive Landscape and Company Profiles. |
| 10. | Porter’s Five Forces Analysis | Yes. |
| 11. | Value Chain Analysis | Yes |
| 12. | PEST Analysis | Yes |
| 13. | Regulatory Landscape | Yes |
| 14. | Technology Landscape | Yes |
| 15. | COVID-19 Impact Analysis | Yes. Exhaustive information for Key Strategies Undertaken by Companies, Impact Assessment of the COVID-19 Pandemic by Region, along with Short-term and Long-term dynamics. |
| 16. | Top startups to watch out for | Yes |
| 17. | Top 3 Trends to Watch | Yes |
| 18. | Top 3 Strategies Followed by Major Players | Yes |
| 19. | Top 3 Predictions by Vantage Market Research | Yes |
| 20. | Discussion Guide | Yes |
| 21. | Key Primary Respondents - VERBATIM | Yes |
| 22. | Transcripts from the Primary Respondents | Additional Cost USD 1,000 |
| 23. | Others/Miscellaneous | |
FAQ
Frequently Asked Question
What is the global demand for Neurodiagnostics in terms of revenue?
-
The global Neurodiagnostics valued at USD XX Billion in 2024 and is expected to reach USD XX Billion in 2034 growing at a CAGR of 7.4%.
Which are the prominent players in the market?
-
The prominent players in the market are GE Healthcare (US), Siemens Healthiness (Germany), Philips Healthcare (Netherlands), Canon, Inc. (Japan), Hitachi, Ltd. (Japan), Lifelines Neuro Company, LLC (US), Natus Medical Incorporated (US), Hoffman-La Roche AG (Switzerland), FUJIFILM Holdings Corporation (Japan), Mitsar Co., Ltd. (Russia), Advanced Brain Monitoring (US), Thermo Fisher Scientific, Inc. (US), Bio-Rad Laboratories (US), QIAGEN N.V. (Netherlands), and Nihon Kohden Corporation (Japan).
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 7.4% between 2025 and 2034.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Neurodiagnostics include
Which region accounted for the largest share in the market?
-
XX was the leading regional segment of the Neurodiagnostics in 2024.
